Li‐hua Ping

发表

Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus.

L. Ping, S. Lemon, J. Stapleton, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Alphavirus Replicon Particles as Candidate HIV Vaccines

Philip R. Johnson, David Montefiori, Maureen F. Maughan, 2002, IUBMB life.

Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs.

L. Ping, S. Lemon, E. A. Brown, 1992, Nucleic acids research.

A Phylogenetically Conserved Stem-Loop Structure at the 5′ Border of the Internal Ribosome Entry Site of Hepatitis C Virus Is Required for Cap-Independent Viral Translation

M. Honda, L. Ping, S. Lemon, 1999, Journal of Virology.

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Hui Li, Tanmoy Bhattacharya, Xiping Wei, 2008, Proceedings of the National Academy of Sciences.

Hepatitis C virus core protein induces apoptosis and impairs cell‐cycle regulation in stably transformed chinese hamster ovary cells

M. Honda, S. Kaneko, Takeo Shimazaki, 2000, Hepatology.

Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections

Feng Gao, Bette Korber, Tongye Shen, 2011, PLoS pathogens.

Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies

L. Ping, S. Lemon, Li‐hua Ping, 1992, Journal of virology.

Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination

L. Ping, S. Lemon, P. Murphy, 1991, Journal of virology.

In vivo replication and reversion to wild type of a neutralization-resistant antigenic variant of hepatitis A virus.

L. Ping, S. Lemon, J. Leduc, 1990, The Journal of infectious diseases.

Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial

T. Quinn, L. Ping, R. Swanstrom, 2017, Journal of acquired immune deficiency syndromes.

Characterization and selection of HIV-1 subtype C isolates for use in vaccine development.

Maureen F. Maughan, R. Johnston, L. Ping, 2003, AIDS research and human retroviruses.

Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape

Lynn Morris, Penny L Moore, Michael S Seaman, 2012, Nature Medicine.

Characterization of V3 Sequence Heterogeneity in Subtype C Human Immunodeficiency Virus Type 1 Isolates from Malawi: Underrepresentation of X4 Variants

P. Vernazza, L. Ping, R. Swanstrom, 1999, Journal of Virology.

Characterization of Glycosylation Profiles of HIV-1 Transmitted/Founder Envelopes by Mass Spectrometry

E. Go, H. Desaire, Haiyan Chen, 2011, Journal of Virology.

Characterization of Glycosylation Proﬁles of HIV-1 Transmitted/Founder Envelopes by Mass Spectrometry (cid:1) †

E. Go, H. Desaire, Haiyan Chen, 2011 .

Limitations to contact tracing and phylogenetic analysis in establishing HIV type 1 transmission networks in Cuba.

Anne-Mieke Vandamme, Philippe Lemey, Sonia Resik, 2007, AIDS research and human retroviruses.

Phenotypic Correlates of HIV-1 Macrophage Tropism

William D. Graham, D. Montefiori, L. Ping, 2015, Journal of Virology.

Ongoing HIV Transmission and the HIV Care Continuum in North Carolina

L. Ping, R. Swanstrom, W. Miller, 2015, PloS one.

Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies

E. L. Potter, Shamit S. Prabhu, H. Ke, 2019, Nature Communications.

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Feng Gao, Hui Li, Guido Ferrari, 2012, The Journal of clinical investigation.

Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants

R. Swanstrom, H. Chu, B. Korber, 2009, Journal of Virology.

A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.

G. Shaw, N. Parrish, L. Ping, 2010, Virology.

Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants

H. Chu, B. Korber, B. Haynes, 2009, Journal of Virology.

HIV-1 Populations in Semen Arise through Multiple Mechanisms

Cassandra B. Jabara, Corbin D. Jones, P. Borrow, 2010, PLoS pathogens.

R5 Macrophage-Tropic HIV-1 in the Male Genital Tract

Shuntai Zhou, R. Swanstrom, I. Hoffman, 2015, Journal of Virology.

Comparison of Viral Env Proteins from Acute and Chronic Infections with Subtype C Human Immunodeficiency Virus Type 1 Identifies Differences in Glycosylation and CCR5 Utilization and Suggests a New Strategy for Immunogen Design

E. L. Potter, Cassandra B. Jabara, H. Chu, 2013, Journal of Virology.

The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells

D. Burton, A. Lanzavecchia, Johannes S. Gach, 2013, PLoS pathogens.

Effects of Genital Tract Inflammation on Human Immunodeficiency Virus Type 1 V3 Populations in Blood and Semen

P. Vernazza, L. Ping, R. Swanstrom, 2000, Journal of Virology.

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

A. Perelson, B. Korber, P. Hraber, 2012, The Journal of clinical investigation.

Strategy for Immunogen Design CCR 5 Utilization and Suggests a New Identifies Differences in Glycosylation and C Human Immunodeficiency Virus Type 1 Acute and Chronic Infections with Subtype Comparison of Viral Env Proteins from

Cassandra, E. L. Potter, Vermeulen, 2013 .

Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.

L. Ping, R. Swanstrom, L. Morris, 2006, Virology.

Characterization and selection of HIV-1 subtype C isolates for use in vaccine development.

Maureen F. Maughan, R. Johnston, S. Karim, 2003, AIDS research and human retroviruses.

Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C

H. Liao, B. Haynes, D. Montefiori, 2013, PloS one.

Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA.

M. Honda, L. Ping, S. Lemon, 1996, Virology.

HIV-1 Transmission during Early Antiretroviral Therapy: Evaluation of Two HIV-1 Transmission Events in the HPTN 052 Prevention Study

Lei Wang, Allen G. Rodrigo, Susan H. Eshleman, 2013, PloS one.